Sevelamer Carbonate
Product Images NDC 10135-660

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 10135-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Chemical Structure Of Sevelamer Carbonate (Sevelamer Carbonate 01)

Figure 1. Chemical Structure Of Sevelamer Carbonate (Sevelamer Carbonate 01)
FDA Label Image

Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Carbonate 02)

Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Carbonate 02)
FDA Label Image

Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Carbonate 03)

Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Carbonate 03)
Sevelamer Hydrochloride is a medication used to treat high levels of phosphorus in the blood. It is considered an Active-Control medication and is used to reduce the amount of phosphorus in patients' blood compared to the baseline levels.*
FDA Label Image

Principal Display Panelndc 10135-0660-68sevelamer Carbonatetablets800 mg270 Tabletsrx Only (Sevelamer Carbonate 04)

Principal Display Panelndc 10135-0660-68sevelamer Carbonatetablets800 mg270 Tabletsrx Only (Sevelamer Carbonate 04)
This is a description of a medication called Sevelamer Carbonate, which is contained in each of the 270 film-coated tablets provided. The active ingredient is 800 mg of Sevelamer Carbonate, while the inactive ingredients are diacetylated monoglycerides, hypromellose, silicon dioxide, and zinc stearate. The dosage instructions can be found in the package insert, and the tablets should be stored at 20-25°C. The tablets should also be protected from moisture, and the container should be tightly sealed. This medication is only available with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.